Benzodiazepines — medications such as Xanax (alprazolam), Valium (diazepam), Klonopin (clonazepam), and Ativan (lorazepam) — are among the most commonly prescribed drugs in the United States. They are prescribed for anxiety, panic disorder, insomnia, and seizures, and many New York State and government employees have received them through legitimate prescriptions. What is less commonly understood is that benzodiazepines can cause physical dependence even when taken as prescribed — and that stopping them abruptly can be medically dangerous. This article is for educational purposes only and is not medical advice.
Benzodiazepines work by enhancing the calming effects of a brain chemical called GABA (gamma-aminobutyric acid), reducing anxiety and promoting sleep. With regular use over weeks or months, the brain adapts to their presence by reducing its own GABA activity. When the medication is then reduced or stopped suddenly, the nervous system can become dangerously overactivated. According to MedlinePlus, a service of the National Library of Medicine, dependence can develop even in people who take these medications exactly as prescribed — which is why doctors typically advise gradual tapering rather than sudden discontinuation.
Severe benzodiazepine withdrawal is a medical emergency. Unlike opioid withdrawal — which is very uncomfortable but rarely directly fatal — withdrawal from benzodiazepines shares a dangerous mechanism with alcohol withdrawal: both can cause grand mal seizures and a condition called delirium tremens, involving severe confusion, agitation, fever, and hallucinations. The National Institute on Drug Abuse (NIDA) identifies benzodiazepines as one of the prescription drug classes associated with the highest risk of dangerous withdrawal. Do not stop benzodiazepines abruptly or without medical guidance. The Substance Abuse and Mental Health Services Administration (SAMHSA) strongly recommends professionally supervised withdrawal management for this class of medication.
The safest approach to stopping benzodiazepines is a medically supervised gradual taper — a structured, slow reduction of the dose that allows the brain and nervous system to readjust without triggering dangerous rebound activity. In a supervised detox setting, a clinical team:
Benzodiazepine withdrawal can be prolonged — lasting weeks or months in some cases — which is why continuous medical supervision throughout the taper is important. The National Institute on Alcohol Abuse and Alcoholism (NIAAA), whose guidance on alcohol withdrawal shares key clinical principles with benzodiazepine management, emphasizes that supervised care reduces life-threatening complications that self-managed withdrawal cannot address.
For New York State and government employees enrolled in NYSHIP — including the Empire Plan and NYSHIP-participating HMOs — medically necessary substance use disorder treatment is generally a covered benefit. Under the federal Mental Health Parity and Addiction Equity Act (MHPAEA), plans that cover mental health and substance use treatment cannot apply more restrictive terms than they apply to comparable medical benefits. Benzodiazepine dependence is a recognized medical condition, and inpatient or residential detox is typically covered when a clinical assessment determines it is medically necessary.
Coverage specifics — including applicable copays, deductibles, prior authorization requirements, and network rules — vary by plan. Visit our NYSHIP rehab coverage page or call us at 631-800-4691 for a free, confidential benefits verification.
A common concern for government employees is whether seeking treatment could affect their employment. Federal law provides strong protections. Substance use disorder treatment records are protected by 42 CFR Part 2, which imposes stricter confidentiality requirements than standard HIPAA — your employer cannot access your treatment records without your explicit written consent. Eligible employees may also be entitled to up to 12 weeks of job-protected leave under the Family and Medical Leave Act (FMLA) for treatment of a serious health condition. These are general legal outlines; confirm specifics with your HR office or a qualified attorney.
Because benzodiazepines are frequently prescribed for anxiety, panic disorder, or insomnia, successful long-term recovery also means addressing those underlying conditions. According to MedlinePlus, anxiety disorders are highly treatable through evidence-based approaches such as cognitive behavioral therapy (CBT) and, where appropriate, non-addictive medications. An integrated approach that treats both the dependence and the original condition gives recovery a much more durable foundation. You can read more on our NYSHIP coverage verification page about how ongoing behavioral health care is typically covered.
If you or a loved one is dependent on benzodiazepines, please do not try to stop alone. For free, confidential, 24/7 treatment referrals, call the SAMHSA National Helpline at 1-800-662-4357. If you or someone you know is in crisis or having thoughts of suicide, call or text the 988 Suicide and Crisis Lifeline. For questions about using NYSHIP or Empire Plan coverage for benzodiazepine detox, call us at 631-800-4691. This content is for educational purposes only and does not constitute medical or legal advice.
Submit your info and our admissions team will confirm your exact NYSHIP / Empire Plan coverage and report back — usually within a few hours. HIPAA & 42 CFR Part 2 protected; your employer is never notified.
Protected under HIPAA and 42 CFR Part 2. Employer, union, and HR are never notified.
Most verifications finish within 2–4 hours during business hours.
24/7 admissions line: 631-800-4691